Literature DB >> 23843313

Synthesis of Neisseria meningitidis serogroup W135 capsular oligosaccharides for immunogenicity comparison and vaccine development.

Chia-Hung Wang1, Shiou-Ting Li, Tzu-Lung Lin, Yang-Yu Cheng, Tsung-Hsien Sun, Jin-Town Wang, Ting-Jen R Cheng, Kwok Kong Tony Mong, Chi-Huey Wong, Chung-Yi Wu.   

Abstract

Entities:  

Keywords:  N. meningitidis; bactericidal; oligosaccharides; total synthesis; vaccine

Mesh:

Substances:

Year:  2013        PMID: 23843313     DOI: 10.1002/anie.201302540

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


× No keyword cloud information.
  15 in total

1.  A Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.

Authors:  Sharavathi Guddehalli Parameswarappa; Katrin Reppe; Andreas Geissner; Petra Ménová; Subramanian Govindan; Adam D J Calow; Annette Wahlbrink; Markus W Weishaupt; Bopanna Ponnappa Monnanda; Roland Lawrence Bell; Liise-Anne Pirofski; Norbert Suttorp; Leif Erik Sander; Martin Witzenrath; Claney Lebev Pereira; Chakkumkal Anish; Peter H Seeberger
Journal:  Cell Chem Biol       Date:  2016-11-03       Impact factor: 8.116

2.  Synthesis and immunological study of α-2,9-oligosialic acid conjugates as anti-group C meningitis vaccines.

Authors:  Guochao Liao; Zhifang Zhou; Zhongwu Guo
Journal:  Chem Commun (Camb)       Date:  2015-06-14       Impact factor: 6.222

3.  Microbe-focused glycan array screening platform.

Authors:  Andreas Geissner; Anika Reinhardt; Christoph Rademacher; Timo Johannssen; João Monteiro; Bernd Lepenies; Michel Thépaut; Franck Fieschi; Jana Mrázková; Michaela Wimmerova; Frank Schuhmacher; Sebastian Götze; Dan Grünstein; Xiaoqiang Guo; Heung Sik Hahm; Jeyakumar Kandasamy; Daniele Leonori; Christopher E Martin; Sharavathi G Parameswarappa; Sandip Pasari; Mark K Schlegel; Hidenori Tanaka; Guozhi Xiao; You Yang; Claney L Pereira; Chakkumkal Anish; Peter H Seeberger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-22       Impact factor: 11.205

4.  Size-Controlled Chemoenzymatic Synthesis of Homogeneous Oligosaccharides of Neisseria meningitidis W Capsular Polysaccharide.

Authors:  Riyao Li; Hai Yu; Saddam M Muthana; Darón I Freedberg; Xi Chen
Journal:  ACS Catal       Date:  2020-02-07       Impact factor: 13.084

5.  A Semi-Synthetic Glycoconjugate Vaccine Candidate for Carbapenem-Resistant Klebsiella pneumoniae.

Authors:  Peter H Seeberger; Claney L Pereira; Naeem Khan; Guozhi Xiao; Elizabeth Diago-Navarro; Katrin Reppe; Bastian Opitz; Bettina C Fries; Martin Witzenrath
Journal:  Angew Chem Int Ed Engl       Date:  2017-10-05       Impact factor: 15.336

6.  Interplay of Carbohydrate and Carrier in Antibacterial Glycoconjugate Vaccines.

Authors:  Tyler D Moeller; Kevin B Weyant; Matthew P DeLisa
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

7.  Probing the influence of protecting groups on the anomeric equilibrium in sialic acid glycosides with the persistent radical effect.

Authors:  Pavan K Kancharla; Takayuki Kato; David Crich
Journal:  J Am Chem Soc       Date:  2014-04-01       Impact factor: 15.419

8.  Fully Synthetic Self-Adjuvanting α-2,9-Oligosialic Acid Based Conjugate Vaccines against Group C Meningitis.

Authors:  Guochao Liao; Zhifang Zhou; Sharad Suryawanshi; Mohabul A Mondal; Zhongwu Guo
Journal:  ACS Cent Sci       Date:  2016-04-04       Impact factor: 14.553

Review 9.  Factors contributing to the immunogenicity of meningococcal conjugate vaccines.

Authors:  Michael Bröker; Francesco Berti; Paolo Costantino
Journal:  Hum Vaccin Immunother       Date:  2016-03-02       Impact factor: 3.452

10.  Multivalent display of minimal Clostridium difficile glycan epitopes mimics antigenic properties of larger glycans.

Authors:  Felix Broecker; Jonas Hanske; Christopher E Martin; Ju Yuel Baek; Annette Wahlbrink; Felix Wojcik; Laura Hartmann; Christoph Rademacher; Chakkumkal Anish; Peter H Seeberger
Journal:  Nat Commun       Date:  2016-04-19       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.